Genetic testing via the Renasight panel was negative for pathogenic mutations, including those associated with X-linked hypophosphatemia (XLH), and whole-exome sequencing revealed no CYP27B1 mutations. Here, CYP27B1 is linked to X-linked hypophosphatemia.